|21st September 2020||Advisors Llc Orbimed||137,500||Open or private sale||$28.00||$3,850,000.00|
|21st September 2020||Capital Management, L.P. Ra||2,145,045||Conversion of derivative||$0.00|
|21st September 2020||Capital Management, L.P. Ra||660,000||Open or private purchase||$19.00||$12,540,000.00|
|17th September 2020||Capital Management, L.P. Ra||1,300,000||Open or private purchase||$28.00||$36,400,000.00|
|15th September 2020||Advisors Llc Orbimed||902,885||Grant/award etc.||$0.00|
|15th September 2020||Advisors Llc Orbimed||4,822,960||Grant/award etc.||$0.00|
|15th September 2020||Advisors Llc Orbimed||292,607||Grant/award etc.||$0.00|
|9th September 2020||Capital Management, L.P. Ra||158,589||Open or private sale||$25.81||$4,092,738.04|
|21st August 2020||Capital Management, L.P. Ra||2,129,003||Conversion of derivative||$0.00|
|18th August 2020||Advisors Llc Orbimed||43,543||Open or private sale||$108.54||$4,726,157.22|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
scPharmaceuticals, Inc. was founded by Pieter Muntendam and Bertram Pitt in February 2013. Its products include furosemide, used as parenteral diuretic in treating heart failure.